Predictive nomogram identifies suboptimal valproate concentrations in pediatric epilepsy patients using daily dose, organ injury, and meropenem.
New tool predicts dangerous valproate levels in children with epilepsy
This retrospective cohort study of 121 pediatric patients with epilepsy aged 2–18 years developed a predictive nomogram to identify suboptim…
A new calculator can flag children with epilepsy who are likely to get unsafe valproate levels, helping doctors adjust doses before problems…
FDA Approves Depakote Sprinkle Capsules (valproate) for Monotherapy and Adjunctive Therapy of Complex Partial and Absence Seizures.
FDA approves a new sprinkle capsule form of the epilepsy drug Depakote.
The FDA approved Depakote Sprinkle Capsules (valproate) for monotherapy and adjunctive therapy of complex partial seizures and simple and co…
FDA approves a sprinkle capsule form of Depakote that patients can open and mix with soft food to help those who struggle to swallow pills.